Phenylpiperazine

Phenylpiperazine

SCHEMBL7248311

Cn1c(CCc2ccc(C#N)cc2)nc2cc(C(=O)O)ccc21.c1ccc(N2CCNCC2)cc1

nearest known ligand 0.46

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HTR2C P28335 1/20 0.46
▸ F2 P00734 1/20 0.45
▸ HDAC1 Q13547 4/20 0.44
▸ HDAC8 Q9BY41 1/20 0.44
▸ GLP1R P43220 2/20 0.44
▸ MAPT P10636 1/20 0.43
▸ TSHR P16473 1/20 0.43
▸ RAB9A P51151 1/20 0.43
▸ POLB P06746 1/20 0.42
▸ KCNH2 Q12809 1/20 0.41
▸ HDAC6 Q9UBN7 2/20 0.40
▸ HSD17B10 Q99714 1/20 0.39
▸ BRD4 O60885 1/20 0.39
▸ CREBBP Q92793 1/20 0.39
▸ HPGD P15428 1/20 0.39
▸ MAPKAPK2 P49137 1/20 0.39
▸ ITK Q08881 1/20 0.39
▸ EHMT2 Q96KQ7 1/20 0.39
▸ EHMT1 Q9H9B1 1/20 0.39
▸ NTRK1 P04629 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7255958 0.93 GLP1R (0.43) HTR2CF2HDAC1HDAC8GLP1R
SCHEMBL7248938 0.90 HTR2C (0.43) HTR2CF2HDAC1HDAC8GLP1R
SCHEMBL7250650 0.89 GLP1R (0.48) HTR2CF2HDAC1HDAC8GLP1R
SCHEMBL6486632 0.87 F2 (0.50) F2HDAC1HDAC8GLP1RMAPT
Hydrochloric Acid SCHEMBL7244675 0.86 F2 (0.49) F2HDAC1HDAC8GLP1RMAPT
SCHEMBL7249842 0.81 F2 (0.43) HTR2CF2HDAC1HDAC8MAPT
SCHEMBL7252575 0.80 THRB (0.44) HTR2CF2HDAC1HDAC8TSHR
SCHEMBL7249812 0.79 PPARG (0.42) HTR2CF2HDAC1HDAC8HDAC6
SCHEMBL7249727 0.79 F2 (0.41) HTR2CF2HDAC1HDAC8MAPT
SCHEMBL7250212 0.79 F2 (0.45) HTR2CF2HDAC1HDAC8MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6512000-B1 Aminocarbonyl- substituted benzimidazole derivatives for the treatment of diseases in which inhibition of tryptase is of therapeutic such as for treating an inflammatory or allergic disease BOEHRINGER INGELHEIM PHARMA KG (DE) 2003-01-28 — — US disclosed
Send feedback